Skip to main content
Scroll Top
Menu
WHO WE ARE
ABOUT US
TEAM
MANAGEMENT TEAM
INDUSTRIAL ADVISORS
SCIENTIFIC COUNCIL
PARTNERS
R&D
INTRODUCTION
TECH
NEUROSTIMULATION
PHOTOBIOMODULATION
ALZHEIMER
CLINICAL TRIAL
PATHOPHYSIOLOGY
TECHNOLOGY
CONCUSSION
CLINICAL TRIAL
PATHOPHYSIOLOGY
TECHNOLOGY
SOLUTIONS
CLINICAL RESEARCH
PRECLINICAL RESEARCH
CONCUSSION
NEWS
ALL
PRESS ARTICLES
VIDEOS
EVENTS
SCIENTIFIC PUBLICATIONS
ALL
SCIENTIFIC ARTICLES
ORAL COMMUNICATIONS
POSTED COMMUNICATIONS
CONTACT
FAQ
Executive summary
Français
Menu
WHO WE ARE
ABOUT US
TEAM
MANAGEMENT TEAM
INDUSTRIAL ADVISORS
SCIENTIFIC COUNCIL
PARTNERS
R&D
INTRODUCTION
TECH
NEUROSTIMULATION
PHOTOBIOMODULATION
ALZHEIMER
CLINICAL TRIAL
PATHOPHYSIOLOGY
TECHNOLOGY
CONCUSSION
CLINICAL TRIAL
PATHOPHYSIOLOGY
TECHNOLOGY
SOLUTIONS
CLINICAL RESEARCH
PRECLINICAL RESEARCH
CONCUSSION
NEWS
ALL
PRESS ARTICLES
VIDEOS
EVENTS
SCIENTIFIC PUBLICATIONS
ALL
SCIENTIFIC ARTICLES
ORAL COMMUNICATIONS
POSTED COMMUNICATIONS
CONTACT
FAQ
Executive summary
Français
Home
Posts by Florence D'Huy
ESCC 2026 – Nice | 10-12 June
Concussions
Past Events
24 August 2026
ESCC 2026 – Nice | 10-12 June
AAIC 2026 – London | 12-15 July
Alzheimer
Past Events
Posted Communications
23 August 2026
AAIC 2026 – London | 12-15 July
REGEnLIFE: a new step towards a practical and accessible treatment to address the public health challenges posed by Alzheimer’s disease.
Alzheimer
22 August 2026
REGEnLIFE: a new step towards a practical and accessible treatment to address the public health challenges posed by Alzheimer’s disease.
Research. Regenlife is testing its technologies for Alzheimer’s disease at Biofortis in Nantes
Alzheimer
22 August 2026
Research. Regenlife is testing its technologies for Alzheimer’s disease at Biofortis in Nantes
Regenlife opens a clinical research centre at Biofortis in Nantes to study Alzheimer’s disease
Alzheimer
22 August 2026
Regenlife opens a clinical research centre at Biofortis in Nantes to study Alzheimer’s disease
REGEnLIFE Appoints Dr. Volker Herrmann as CEO to accelerate corporate growth and global expansion
Past Events
22 August 2026
REGEnLIFE Appoints Dr. Volker Herrmann as CEO to accelerate corporate growth and global expansion
SantExpo 2026 – Paris / Porte de Versailles | 21 MAI
Alzheimer
Past Events
28 May 2026
SantExpo 2026 – Paris / Porte de Versailles | 21 MAI
The Microbiome at the Heart of Tomorrow’s Therapies – Narbonne | 16 & 17 April 2026
Alzheimer
Past Events
Posted Communications
28 May 2026
The Microbiome at the Heart of Tomorrow’s Therapies – Narbonne | 16 & 17 April 2026
Montpellier: Regenlife sheds light on the fight against Alzheimer’s disease
Alzheimer
28 May 2026
Montpellier: Regenlife sheds light on the fight against Alzheimer’s disease
A helmet and a belt to slow the progression of Alzheimer’s disease: an ingenious idea being tested at the Hospices Civils de Lyon
Alzheimer
28 May 2026
A helmet and a belt to slow the progression of Alzheimer’s disease: an ingenious idea being tested at the Hospices Civils de Lyon
Alzheimer’s disease: REGEnLIFE accelerates its Light4Life clinical trial with the opening of a new trial site at Lyon University Hospital, Hôpital des Charpennes
Alzheimer
1 April 2026
Alzheimer’s disease: REGEnLIFE accelerates its Light4Life clinical trial with the opening of a new trial site at Lyon University Hospital, Hôpital des Charpennes
MedInTechs 2026 – Parc Floral de Paris | 9 & 10 March
Alzheimer
Past Events
20 March 2026
MedInTechs 2026 – Parc Floral de Paris | 9 & 10 March
1
2
3
Next
Get a Quote
Hidden fields
